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Abstract
Propensity Score Matching (PSM) is an useful method to reduce the impact ofTreatment -
Selection Bias in the estimation of causal effects in observational studies. After matching, the
PSM significantly reduces the sample under investigation, which may lead to other possible
biases. In this sense, we want to analyse the behaviour of this PSM compared with other
widely used method to deal with non-comparable groups, as is the Multivariate Regression
Model (MRM). Monte Carlo Simulations are made to construct groups with different effects in
order to compare the behaviour of PSM and MRM estimating this effects. Also the Treatment
- Selection Bias reduction for the PSM is calculated. With the PSM a reduction in the
Treatment - Selection Bias is achieved, with a reduction in the Relative Real Treatment Effect
Estimation Error, but despite of this bias reduction and estimation error reduction, the MRM
significantly reduces more this estimation error compared with the PSM. Also the PSM leads
to a not insignificant reduction of the sample. This loss of information derived from the
matching process may lead to another not known bias, and thus, to the inaccurate of the effect
estimation compared with the MRM.
Keywords: Propensity Score Matching, Multivariate Analysis, General Linear Model, Monte
Carlo Method, Causal Effect Estimation, Observational Study.
Abreviations: PS: Propensity Score, PSM: Propensity Score Matching, RTE: Real Treatment
Effect, GLM: General Linear Model, MRM: Multivariate Regression Model.
1
ar
X
iv
:1
90
1.
09
88
3v
2 
 [s
tat
.M
E]
  3
0 J
an
 20
19
1 Introduction
Propensity Score Matching (PSM) is an useful method to reduce the impact of treatment-
selection bias in the estimation of causal effects in observational studies. Since firstly described by
Rosenbaum and Rubin in 1983 [1], its utility in Medicine, Psicology, Economics and other fields,
has increased exponentially in the last years [2]. Although it does not bypass the necessity for
randomised studies, it may be an alternative to reduce the impact of treatment-selection bias in
observational studies.
The Propensity Score (PS) is defined as the subject’s probability of receiving a specific treatment
conditional on the observed covariates [1]. After stratification by its PS, treated and untreated
patients are matched by their PS with the most similar individuals of the opposite group. It leads
to a more similar distribution of baseline characteristics between treated and untreated subjects,
and it have been demonstrated that this method reduces the Treatment-selection bias [4, 5].
Once two comparable groups have been obtained, researchers treat this studies like more similar
to randomised studies (although it does not substitute this randomised studies), and use them as
a reasonable alternative for observational studies [3]. In this sense, it is thought that because PSM
controls the possible treatment-selection bias, it would be possible to directly measure the effects in
both matched groups, and thus, it may be better for observational studies than other multivariate
adjustment methods.
One important concern is the influence of the not insignificant loss of non matched individuals
that may be seen in some works using this PSM method [6], and who are not used for posterior
analysis. Because we need to eliminate enough unmatched individuals to guarantee in some way the
Treatment - Selection Bias correction, it is not possible to know if the elimination of this unmatched
individuals can cause some loss of information that in other ways would be analysed, and therefore
lead us to a non controlled bias. In this sense other authors have reported the over-employment of
this technique and its potential implications in potential biases [10,11].
Moreover, although we are controlling the Treatment - Selection Bias, after matching we are
directly measuring the effect in both matched groups. In this way, its behaviour compared with
a multivariate adjustment method, which is widely used to control groups for other possible con-
founders, has never been tested. Given that there is a loss of individuals prior to the analysis,
we do not know if this loss of information can variate the results obtained with the multivariate
analysis.
Because of that, we wanted to test the behaviour of PSM in different situations, compared with
a multivariate analysis based on General Linear Models (GLM), in the estimation of treatment
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effects. For this purpose we developed a theoretical Montecarlo Method of treatment effects in
which we applied the PSM and a multivariate analysis based on a GLM to compare their ability
to estimate the Real Treatment Effect (RTE) in each situation.
2 Methods
2.1 Theoretical Multivariate model
Suppose Yz(x) the patient z probability for a certain event. Its probability may be influenced
by a series of independent variables Azj and Bzk each one of them with a concrete weight in this
patient probability prediction qj and sk respectively. Azj variables may be related to the received
treatment and Bzk variables are supposed to be independent of the received treatment. It may
be also influenced by the treatment status Xz of the patient, which may confer some protection t
against the event under study.
For each patient there may be also some unmeasured influence z in its event probability, which
may vary from patient to patient and may be because some unknown or non measured variables.
We consider it as a random variable, which may be based in a normal distribution:
z ∼ N (0, 1) (1)
Each patient may present some different characteristics. A part from this Azj and Bzk charac-
teristics that may predispose in some way the probability for the event under study, it may present
other variables unrelated with the event under study. Some of them may predispose to receive the
treatment under study Cl and others Dm may be unrelated to either patient outcomes or treatment
predisposition.
For a concrete patient the logit of the probability for a certain event may be predicted by the
formula:
Yz(x) = Xzt+Az1q1 + ...+Azjqj +Bz1s1 + ...+Bzksk + z (2)
And thus the theoretical event probability for a z given patient will be:
ρz =
eYz(x)
1 + eYz(x)
(3)
2.2 Monte Carlo Simulations
Once the theoretical model is build, Monte Carlo Simulations are made to construct groups for
a posterior analysis. Simulated experiments under this conditions are made, and an event status
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Ez is assigned to each patient z in each simulated experiment, based on a binomial distribution
with ρz probability.
Ez ∼ B(n, ρ) = B(1, ρz) (4)
The theoretical (real) treatment effect is modified after each group of simulations, ranging from
a 0 (null) effect to a 5 fold event reduction, in 0.1 intervals.
2.3 Unadjusted Model
The Odds Ratio for the event prevention under Treatment status is calculated with a univariable
General Linear Model (GLM). For each experiment, with the complete matrix of events Y and
treatment X status, a GLM is build to estimate the unadjusted estimated risk prevention effect
for the treatment tua:
Y = Xtua + U (5)
From this built model, the estimated Odds Ratio for the RTE ORua is calculated:
ORua = e
tua (6)
Since this measured Odds Ratio does not take in account other variables, it will be named the
unadjusted Odds Ratio and it will be considered the reference for the improvement in the RTE
estimation.
2.4 Multivariate Regression Model
For control purposes a Multivariate Regression Model (MRM) is build for each experiment with
all the variables under analysis. In each experiment the complete matrix of events Y , treatment
status X and analysed variables A, B, C and D are used to build the MRM and estimate the
multivariate adjusted event reduction of the treatment tmulti:
Y = Xtmulti +Aqmulti +Bsmulti + Cumulti +Dvmulti + U (7)
From this built model, the estimated Odds Ratio for the RTE (Multivariate Odds Ratio,
ORmulti) is calculated:
ORmulti = e
tmulti (8)
It will be used as the gold standar for the estimation of the RTE.
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2.5 Propensity Score Matching Model
PSM is used to estimate the Treatment Effect. As described early, the PS is build based on a
MRM designed to estimate each patient’s predisposition to receive the treatment under investiga-
tion. In each patient the PS is calculated for posterior matching between treated and untreated
individuals. For the matching the nearest method is used, with a caliper of 0.2.
Once matched is done, the treatment effect is estimated based on a GLM. For each experiment,
the matrix of matched individuals with the events Ymatch and treatment Xmatch status are used
to build a GLM to estimate the estimated risk prevention effect for the treatment tmatch:
Ymatch = Xmatchtmatch + U (9)
From this built model, the estimated Odds Ratio for the RTE ORmatch is calculated:
ORmatch = e
tmatch (10)
2.6 Statistical Analysis
For each treatment effect situation, RTE Estimation is measured with each one of the three
described methods. This RTE estimation is lately compared with the RTE to calculate the inaccu-
rate of the RTE Estimation (Relative RTE Estimation Error). Al variables are expressed as mean
+/- 95% Confidence Interval. The comparison of the RTE Estimation Error between the three
described methods is done with a multivariate analysis of variance (MANOVA test).
For the MRM and the PSM Model, the RTE Estimation Error is compared with the Unadjusted
Model, to calculate the Relative RTEE Estimation Error Reduction for each one. The comparison
of this Relative RTEE Estimation Error Reduction between MRM and PSM Model is done with a
paired T Test.
For the Unadjusted Model and the PSM Model the Treatment-Selection Bias is calculated with
a Pearson’s chi-squared test to evaluate the homogeneity between groups. The comparison of the
Treatment - Selection bias between both models is done with a paired T Test comparing the the
chi-squared test statistic of both models, and the reduction in the Treatment - Selection bias with
the PSM Model is expressed as mean +/- 95% Confidence Interval.
For the PSM Model the percentage of excluded patients in each analysis will be also analysed.
This will be expressed as the mean of the percentage exclusions in each analysis and the 95%
Confidence Interval of the percentage exclusions in each analysis.
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Figure 1: Comparison of the Propensity Score Matching Model Treatment-Selection Bias reduction,
Percentage of Matched Individuals and Relative Real Treatment Effect Estimation Reduction with
the Multivariate Model Relative Real Treatment Effect Estimation Reduction.
2.7 Analysis Software
For the data generation with the Monte Carlo Simulations and the posterior analysis, the open
software R [8] and the R library MatchIt [9] were used. All wrote code for this purpose is available
through the PropensityScoreReview repository [7].
3 Results
3.1 Monte Carlo Simulations
A total of 5 ·106 Montecarlo Simulations are done. There are 50 blocks of experiments, each one
with a different real treatment effect. In each block of experiments, each experiment is simulated
with 500 individuals and later repeated 200 times for each real treatment effect.
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T-S Bias
Real Treat-
ment Effect
Unadjusted
Model
Matched
Model
p
Value
T-S Bias Re-
duction
Excluded Pa-
tients (%)
5 220.7 (217.82,
223.57)
3.631 (3.479,
3.783)
<0.001 0.983 (0.983,
0.984)
70.66 (70.2,
71.12)
4 219.09 (216.36,
221.83)
3.599 (3.446,
3.751)
<0.001 0.983 (0.983,
0.984)
70.43 (69.98,
70.88
3 219.1 (216.29,
221.90)
3.698 (3.536,
3.861)
<0.001 0.983 (0.982,
0.984)
70.55 (70.1,
71)
2 217.6 (214.80,
220.33)
3.721 (3.576,
3.866)
<0.001 0.983 (0.982,
0.983)
70.12 (69.68,
70.56)
1 216.98 (214.31,
219.66)
3.738 (3.603,
3.873)
<0.001 0.982 (0.982,
0.983)
70.19 (69.72,
70.65)
0 219.47 (216.85,
222.09)
3.684 (3.532,
3.835)
<0.001 0.983 (0.982,
0.984)
70.21 (69.77,
70.65)
Table 1: Treatment - Selection Bias for the Unadjusted Model and the Propensity Score Matching
Model. Treatment - Selection Bias Reduction for the Propensity Score Matching Model. Percentage
of excluded patients for the Propensity Score Matching Model. T-S Bias: Treatment - Selection
Bias.
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3.2 Treatment - Selection Bias reduction with Propensity Score Match-
ing
The PSM Model significantly reduces the Treatment - Selection Bias in all scenarios. As seen
in table 1 and Figure 2, there is a Relative Treatment - Selection Bias reduction of about 0.98 in
all scenarios. The main problem of this model is the important number of excluded patients (there
is only a 70% of patients that are included for the analysis).
3.3 Real Treatment Effect Estimation and Relative Real Treatment Ef-
fect Estimation Error Reduction with Propensity Score Matching
Model and Multivariate Regression Model
As it can be seen in figure 2 and 3, and table 2, the PSM Model and the MRM significantly
estimate a more accurate RTE than the Unadjusted Model. This PSM Model and RMM present
a significantly reduced Relative RTE Estimated Error, compared with the Unadjusted Model.
The MRM also present a Relative RTE Estimated Error significantly lower than the PSMModel,
which leads to a significantly increased Relative RTE Estimated Error Reduction compared with
the PSM Model.
4 Discussion
PSM has been widely used in different subjects for Treatment - Selection Bias reduction. As
we shown in this present work, and as it was seen in previous works [3], with this method we can
correct the Treatment - Selection Bias properly, obtaining two comparable groups, so we can thus
directly measure the effect under investigation. In this sense, in our work the Treatment - Selection
Bias practically disappears with the PSM (Treatment - Selection Bias reduction of 0.982 - 0.983
among all scenarios).
As we mentioned earlier, our main concern about the PSM method is the percentage of un-
matched individuals and its possible influence in the posetrior estimation of RTE. In our work
results there is a not insignificant reduction of the sample, with a percentage of analysed individu-
als of 70.12 to 70.66% from the total of individuals under investigation. And what we can not know
is if this important reduction in the population for analysis may lead to another non controlled
bias, since the excluded patients may have some characteristics that we are obviating for posterior
analysis.
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Figure 2: Comparison of Real Treatment Effect and Real Treatment Effect Estimation from the
Unadjusted Model, Multivariate Regression Model and Propensity Score Matching Model.
Other widely used methods, such as MRM, do not deal with two comparable populations,
but instead, they weigh the different variables under study. Despite dealing with non-comparable
groups, thanks to this weighting of the analysed variables, it can solve in a different way the problem
of the Treatment - Selection Bias. Also, since no individual is eliminated from the analysis, there
is no loss of information, reducing other potential biases that may appear in the PSM method.
In our present work, although both (PSM and MRM) reduce the Relative RTE Estimation
Error, this reduction is better with the MRM, compared with the PSM. This best performance
of the MRM may confirm our previous preoccupation about the possible influence of the sample
reduction on the posterior estimation of the RTE.
Since there may be a significant reduction of the sample under analysis when we are using a
PSM method, we have to take it in account before accepting the obtained results, specially when
this reduction is important. Other multivariate methods should always be done, in addition to the
PSM analysis, and both results compared, in order to seek for a possible uncontrolled bias. If a
significant difference is obtained between both analysis, we have to suspect a possible bias derived
from the sample reduction, once the matching has been done.
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Figure 3: Comparison of Relative Real Treatment Effect Estimation Error with the Unadjusted
Model, Multivariate Model and Propensity Score Matching Model.
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